Clinical Trial Update: (CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial named CLONEVO is investigating cell cycle inhibition to target urothelial (bladder) cancer; the study is active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Bladder Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING